Although there is limited literature available on this specific relationship, one possible hypothesis is that elevated levels of IL-10 in non-metastatic tumours may contribute to the subsequent transition to metastatic disease, ultimately resulting in poorer survival outcomes. This evidence concerns the gene IL10 and neoplasm.